Home › Membranous Glomerulonephritis › California
Membranous Glomerulonephritis clinical trials in California
3 studies for Membranous Glomerulonephritis are looking for participants at sites in California.
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
- Academic Medical Research Institute, Los Angeles
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Oct 1, 2026 · NCT07851220Belimumab With Rituximab for Primary Membranous Nephropathy
- University of California San Francisco, San Francisco
- Stanford University School of Medicine: Division of Nephrology, Stanford
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- and 1 more
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.